Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months

被引：0
|
作者：
A. D. Anastasilakis
S. A. Polyzos
P. Makras
A. Gkiomisi
I. Bisbinas
A. Katsarou
A. Filippaios
C. S. Mantzoros
机构：
[1] 424 General Military Hospital,Department of Endocrinology
[2] Aristotle University of Thessaloniki,Department of Medicine, Second Medical Clinic, Ippokration General Hospital
[3] 251 Hellenic Air Force & VA General Hospital,Department of Endocrinology and Diabetes
[4] 424 General Military Hospital,Department of Obstetrics and Gynaecology
[5] 424 General Military Hospital,2nd Department of Orthopaedics
[6] Hellenic Military School of Medicine,Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center
[7] Harvard Medical School,undefined
来源：
Osteoporosis International | 2014年 / 25卷
关键词：
Bone metabolism; Denosumab; Fracture; Irisin; Osteoporosis; Teriparatide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1633 / 1642
页数：9
相关论文
共 50 条
  • [41] PREVALENCE OF OSTEOPOROSIS AND LOW BONE MASS IN POSTMENOPAUSAL WOMEN WITH VERTEBRAL COMPRESSION FRACTURES
    Lu, C. -H.
    Lu, Y. -C.
    Chan, W. P.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S717 - S718
  • [42] PREVENTING BONE LOSS IN POSTMENOPAUSAL WOMEN WITH LOW BONE MASS AND LOW-TRAUMA FOREARM FRACTURES
    Cirstoiu, C. F.
    Popescu, D.
    Ene, R.
    Cirstoiu, M.
    Popescu, A.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 143 - 144
  • [43] Greater Gains in Spine and Hip Strength for Romosozumab Compared With Teriparatide in Postmenopausal Women With Low Bone Mass
    Keaveny, Tony M.
    Crittenden, Daria B.
    Bolognese, Michael A.
    Genant, Harry K.
    Engelke, Klaus
    Oliveri, Beatriz
    Brown, Jacques P.
    Langdahl, Bente L.
    Yan, Chris
    Grauer, Andreas
    Libanati, Cesar
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (09) : 1956 - 1962
  • [44] Strength at the Lumbar Spine and Hip Improves with Romosozumab Compared with Teriparatide in Postmenopausal Women with Low Bone Mass
    Keaveny, T. M.
    Crittenden, D. B.
    Bolognese, M. A.
    Genant, H. K.
    Engelke, K.
    Oliveri, B.
    Brown, J. P.
    Langdahl, B. L.
    Yang, Y. C.
    Grauer, A.
    Libanati, C.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [45] A LOW WHOLE-BODY LEAN MASS FACILITATES THE OCCURRENCE OF "OSTEOPOROTIC" FRACTURES ONLY IN POSTMENOPAUSAL WOMEN
    Capozza, R. F.
    Cure-Cure, C.
    Cointry, G. R.
    Meta, M.
    Cure-Ramirez, P.
    Rittweger, J.
    Ferretti, J. L.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 (01) : 172 - 173
  • [46] Effect of Teriparatide Treatment on Circulating Periostin and Its Relationship to Regulators of Bone Formation and BMD in Postmenopausal Women With Osteoporosis
    Gossiel, Fatma
    Scott, Jessica R.
    Paggiosi, Margaret A.
    Naylor, Kim E.
    McCloskey, Eugene V.
    Peel, Nicola F. A.
    Walsh, Jennifer S.
    Eastell, Richard
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (04): : 1302 - 1309
  • [47] Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18 months of teriparatide therapy in postmenopausal women with osteoporosis
    H. M. Macdonald
    K. K. Nishiyama
    D. A. Hanley
    S. K. Boyd
    Osteoporosis International, 2011, 22 : 357 - 362
  • [48] Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18 months of teriparatide therapy in postmenopausal women with osteoporosis
    Macdonald, H. M.
    Nishiyama, K. K.
    Hanley, D. A.
    Boyd, S. K.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 (01) : 357 - 362
  • [49] Genetic variants in the PLS3 gene are associated with osteoporotic fractures in postmenopausal Chinese women
    Shao, Chong
    Wang, Yi-wen
    He, Jin-wei
    Fu, Wen-zhen
    Wang, Chun
    Zhang, Zhen-lin
    ACTA PHARMACOLOGICA SINICA, 2019, 40 (09) : 1212 - 1218
  • [50] Genetic variants in the PLS3 gene are associated with osteoporotic fractures in postmenopausal Chinese women
    Chong Shao
    Yi-wen Wang
    Jin-wei He
    Wen-zhen Fu
    Chun Wang
    Zhen-lin Zhang
    Acta Pharmacologica Sinica, 2019, 40 : 1212 - 1218
12345